Results 141 to 150 of about 15,536 (197)

Brain-kidney crosstalk in subarachnoid hemorrhage patients. [PDF]

J Crit Care Med (Targu Mures)
Monteiro E, Rocha E Silva S, Barbosa S, Barroso I, Dias CC, Czosnyka M, Paiva JA, Dias C.   +7 more
europepmc   +1 more source

Aneurysmal degeneration of venous bypass from drug-eluting stent. [PDF]

J Vasc Surg Cases Innov Tech
Teh R, Doric P, Garbowski M.
europepmc   +1 more source

Longitudinal assessment of sNfL and sGFAP in severe NMOSD treated with allogeneic stem cell transplantation. [PDF]

Front Immunol
Srpova B, Krasulova E, Noskova L, Cichrova M, Kalousova M, Valkova V, Trneny M, Kral V, Havrdova EK, Nytrova P.   +9 more
europepmc   +1 more source

Empagliflozin modulates microRNA expression in human primary cardiomyocytes under CoCl₂-induced hypoxia. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Samec M, Baranova I, Dibdiakova K, Samec I, Samos M, Pec MJ, Pecova R, Pec M.   +7 more
europepmc   +1 more source

Consistency of Serial CSF alpha-Synuclein Seed Amplification Assay Results in the Parkinson’s Progression Marker Initiative

Coughlin DG, Gochanour C, Yin J, Concha-Marambio L, Farris C, Ma Y, Lafontant D, Jabbari E, Simuni T, Marek K, Tropea TF, the Parkinson’s Progression Marker Initiative.   +11 more
europepmc   +1 more source

Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy.

JAMA Netw Open
Miner AE, Zetterberg H, Blennow K, Groh JR, Singh A, Dieckhoff K, Tripodis Y, Adler CH, Balcer LJ, Bernick C, Peskind E, Asken BM, Tanner JA, Rabinovici GD, Banks SJ, Barr WB, Wethe JV, Cantu RC, Dodick DW, Mez J, Palmisano JN, Martin B, Stein TD, McKee AC, Cummings JL, Shenton ME, Reiman EM, Stern RA, Ashton NJ, Alosco ML, DIAGNOSE CTE Research Project.   +30 more
europepmc   +1 more source

Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial.

JAMA Neurol
Gwathmey KG, Saccà F, Howard JF, Vu T, Xi J, Mäurer M, Ruck T, Shin HY, Takahashi MP, Casasnovas C, Smilowski M, Peric S, Masuda M, Scholz J, Shang S, Yee M, Rakhade S, Annane D.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Marek's Disease Virus

1985
Publisher Summary Marek's disease (MD)—a malignant lymphomatosis in chickens—is caused by Marek's disease virus (MDV) of the family Herpesviridae. This chapter reviews recent advances in MD research, especially in the field of molecular biology. Various antigens present in MDV virions, MDV-infected cells, or MD lymphoma cells have been suspected as ...
S, Kato, K, Hirai
openaire   +2 more sources

Marek's Disease: A Review

World's Poultry Science Journal, 1969
(1969). Marek's Disease: A Review. World's Poultry Science Journal: Vol. 25, No. 1, pp. 35-45.
openaire   +2 more sources

A study of vaccination against Marek's disease with an attenuated Marek's disease virus

Avian Pathology, 1974
Approximately 2,000 day-old white leghorn chickens were distributed into 10 pens and half the pens vaccinated with the attenuated strain of HPRS-16. At 72 weeks of age, mortality from non-specific death and Marek's disease was 17.6% and 15.6% respectively, in vaccinated chickens compared with 14.2% and 51.7% in unvaccinated chickens.
C A, Jackson, P M, Biggs, R A, Bell, F M, Lancaster, B S, Milne   +4 more
openaire   +2 more sources